First in Human Study of M6223

Clinical trial NCT04457778 · COMPLETED

Trial details

NCT number: NCT04457778
Sponsor: EMD Serono Research & Development Institute, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Solid Tumors

Start date: 2020-07-10
Primary completion: 2023-06-23
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.